aTyr Pharma, Inc. ATYR
ATYR
aTyr Pharma, Inc. ALXO
ALX Oncology Holdings Inc. CAMP
CAMP4 Therapeutics Corporation QNCX
Quince Therapeutics, Inc. MGX
Metagenomi, Inc. Common Stock RPTX
Repare Therapeutics Inc. UNCY
Unicycive Therapeutics, Inc. RLMD
Relmada Therapeutics, Inc. ACRV
Acrivon Therapeutics, Inc. Common Stock HYFT
MindWalk Holdings Corp.
aTyr Pharma, Inc. ALXO
ALX Oncology Holdings Inc. CAMP
CAMP4 Therapeutics Corporation QNCX
Quince Therapeutics, Inc. MGX
Metagenomi, Inc. Common Stock RPTX
Repare Therapeutics Inc. UNCY
Unicycive Therapeutics, Inc. RLMD
Relmada Therapeutics, Inc. ACRV
Acrivon Therapeutics, Inc. Common Stock HYFT
MindWalk Holdings Corp.
Performance
| Periode | ATYR | ALXO | CAMP | QNCX | MGX | RPTX | UNCY | RLMD | ACRV | HYFT |
|---|---|---|---|---|---|---|---|---|---|---|
| 6M | -86.63 % | 169.00 % | 383.45 % | 168.12 % | 18.75 % | 53.79 % | -22.02 % | 535.50 % | 98.36 % | 97.65 % |
| YTD | -81.26 % | -8.33 % | 42.19 % | 96.81 % | -54.88 % | 68.94 % | -25.76 % | 899.78 % | -57.47 % | 273.33 % |
| 1Y | -75.82 % | -7.14 % | 10.22 % | 93.72 % | -45.02 % | 39.38 % | -16.00 % | 1 057.41 % | -65.43 % | 290.70 % |
| 3Y | -57.65 % | -86.29 % | -34.61 % | 475.70 % | -83.41 % | -85.46 % | -17.18 % | 434.12 % | -79.82 % | -65.78 % |
| 5Y | -57.65 % | -98.36 % | -34.61 % | -88.23 % | -83.41 % | -93.42 % | -88.24 % | -35.44 % | -85.46 % | -84.15 % |
| 10Y | -57.65 % | -95.23 % | -34.61 % | -88.75 % | -83.41 % | -92.76 % | -88.24 % | 52.03 % | -85.46 % | -61.64 % |
| Depuis le début | -57.65 % | -95.23 % | -34.61 % | -88.75 % | -83.41 % | -92.76 % | -88.24 % | -62.50 % | -85.46 % | -61.64 % |